general electric co (GE:New York)

Executive Profile*

Background*

Ms. Susan E. Siegel, Sue, has been Corporate Vice President of General Electric Company since May 2012. Ms. Siegel serves as a Vice President of On-site Operations at Take Care Employer Solutions, LLC. Ms. Siegel is employed at GE Healthcare Financial Services Inc., Investment Arm. She leads Healthy imagination by tapping into GE’s cross-company resources, scale and reach to measurably improve health cost, quality and access globally. She oversees healthcare innovation, ... new models for health delivery, consumer engagement, product alignment and partnerships. Ms. Siegel is also part of General Electric. Ms. Siegel was a General Partner at Mohr Davidow Ventures. Ms. Siegel joined Mohr Davidow Ventures in 2007 and was responsible in leading investments spanning enabling technology platforms, molecular diagnostics and digital health, which leveraged the convergence of these disciplines in driving personalized, consumer-driven and information-based healthcare. Ms. Siegel arrived after a distinguished career as a corporate leader and with a background in biochemistry and molecular biology. She partners with entrepreneurs and companies that offer solutions to pressing healthcare challenges like age-onset conditions, lifestyle-induced health trends, consumer-driven wellness preservation, and those that improve healthcare economics. Ms. Siegel co-founded Stanford Hospital, Checking-In. She has over 25 years experience commercializing key enabling technologies in biomedical research and healthcare. She serves as an Executive Officer of GE Healthcare Bio-Sciences UK Ltd. She served as President Emeritus of Affymetrix Inc., until March 22, 2007. Ms. Siegel served as the President of Affymetrix Inc., which she joined in 1998 to lead the commercialization efforts for its state-of-the-art GeneChip technology. From April 1998 to August 1999, she served as its Senior Vice President, Marketing and Sales. She was part of the Amersham Pharmacia Biotech organization, where she served as the President for the Hoefer Pharmacia Biotech business unit. Prior to Amersham Pharmacia Biotech, Ms. Siegel was employed at E.I. Du Pont, Bio Image/Kodak, and Bio-Rad Laboratories, Inc. She serves as Chairman of the Board at Crescendo Bioscience, Inc. She served as Chairman of the Board of On-Q-ity Inc. She serves as a Director of Personalis, Inc., National Venture Capital Association, Corventis, Crescendo Bioscience, Inc., J. David Gladstone Institutes, Navigenics, Inc., DVS Sciences, Pacific Biosciences of California, Inc., and RainDance Technologies. Ms. Siegel serves as an Advisor to the Institute of Medicine. She served as a Director of CELLective Dx Corporation. She served as a Director of Affymetrix Inc., until April 19, 2006. She is an Emeritus Board Member of The Tech Museum of Innovation, Silicon Valley. Ms. Siegel was elected as a Henry Crown Fellow of the Aspen Institute in 2003. She has served as a Regional Panelist for the selection of White House Fellows, on the Council on Biotechnology Research, Innovation, and Public Policy for the Center for Strategic and International Studies, and on the IBM Life Sciences and Healthcare Strategic Advisory Council. Ms. Siegel was named a Silicon Valley Woman of Influence. Ms. Siegel holds an M.S. in Biochemistry and Molecular Biology from Boston University Medical School, where she studied cellular differentiation in mouse embryonic carcinoma stem cells and a B.S. in Biology from the University of Puerto Rico.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
GE:US	$23.49 USD	+0.0301

COMPETITOR COMPENSATION